This article discusses the production process of the major influenza antigen, hemagglutinin (HA), by rDNA methods in E. coli.
Alan Shaw, PhD
Advertisement
President and CEO of VaxInnate
Articles by Alan Shaw, PhD
Advertisement
Latest Updated Articles
Vaccines Incorporating Toll-Like Receptor LigandsPublished: October 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
2
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
3
Analytics, Automation, and Quality Driving the Next Era of Drug Development
4
Trends in Formulation eBook October 2025
5
